Pfizer Inc. and BioNTech SE today announced the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application for the companies' LP.8.1-adapted monovalent COVID-19 vaccine (COMIRNATY® LP.8.1; COVID-19 Vaccine, mRNA) for use in adults aged 65 years and older.
Read More
